Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Interviews

Latest Interviews

Abu Al-Fadl, a young boy diagnosed early with tuberculosis, sits with his father and an MSF health promoter at Mustafa Al-Adhari Health Center in Sadr City. After completing his treatment, he has recovered and will soon return to school.. Photo Credit: Deniz Fahmi/MSF
Interview
Interview |
24 March 2026
Tuberculosis

How TB Treatment Decision Algorithms Help Diagnose Children: A Paediatrician’s Experience

3 min
A nurse at work at Zugdidi regional TB hospital, in Georgia’s Samegrelo region, where MSF first started working in 2006.  “The question people ask me most often is, ‘aren’t you afraid of working here?’ I tell them, ‘of course not.’ And I give them more information about TB.”
Interview
Interview |
16 March 2020
COVID-19

Challenges in supporting COVID-19 response

Interview
Interview |
03 December 2019
Vaccines
NigeriaGreeceSyria

Saving children’s lives with PCV - An interview with Miriam Alia, Vaccination Advisor

6 min
Interview
Interview

3 Questions With Jessica Burry, Pharmacist

2 min
Interview
Interview

3 Questions With Teri Roberts, Diagnostics Expert

1 min
2nd anniversary of the ARV programme in Khayelitsha, a township near Cape Town, South Africa. Eric Goemaere, HoM, giving a speech Photograph by Eric Miller
Interview
Interview

3 Questions With Eric Goemaere, Doctor

2 min
In March 2017, organisations from 17 European countries filed an opposition to Gilead Science's patent on the highly effective hepatitis C drug sofosbuvir. On 13th and 14th of September 2018, the hearing took e place before the European Patent Office in Munich.  Activists held a protest in front of the European Patent Office for affordable medicines at the start of proceedings on 13 September. Photograph by Peter Bauza
Interview
Interview

3 Questions With Shailly Gupta, Communications Advisor

2 min
Laboratoire. Sur la photo Dr. Bernard Pecoul. Une equipe MSF est presente a Khao-i-Dang, hopital de reference pour les personnes deplacees de la frontiere. Photograph by J. Glory
Interview
Interview

‘We Had to Do Something’ - Beginnings of the Access Campaign

4 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury